Proteins and Peptides

29 Jun 2007 A 4-Week Therapy with Transition Therapeutics' E1-I.N.T.(TM) Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
29 Jun 2007 OMRIX Biopharmaceuticals Completes Patient Enrollment in Fibrin Patch Phase 1 Clinical Trial
29 Jun 2007 Protalex Reports Clinical Progress of PRTX-100 in Rheumatoid Arthritis and Idiopathic Thrombocytopenic Purpura
28 Jun 2007 Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
28 Jun 2007 Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target
28 Jun 2007 Alseres Pharmaceuticals Announces FDA Clearance to Increase Dose Level in Cethrin(R) Phase I/IIa Clinical Trial for Acute Spinal Cord Injury at U.S. Sites
27 Jun 2007 ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
26 Jun 2007 Generex Biotechnology to Initiate Phase III Clinical Trial of Generex Oral-lyn in 2007 Third Quarter
26 Jun 2007 PEGINTRON(TM) and REBETOL(R) Combination Therapy Approved in European Union for Treating Hepatitis C in Patients Coinfected With HIV
26 Jun 2007 Affymax(R) Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia
26 Jun 2007 Bentley Reports Positive Results with Nasulin(TM) Intranasal Insulin Spray at the American Diabetes Association Meeting
25 Jun 2007 BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
24 Jun 2007 SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
24 Jun 2007 BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
22 Jun 2007 Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
22 Jun 2007 Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
21 Jun 2007 Shire in-licenses JUVISTA(R) (human TGFβ3) from Renovo
21 Jun 2007 Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
21 Jun 2007 King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
20 Jun 2007 ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
20 Jun 2007 Merck Serono and Ambrx to collaborate on development of next generation growth hormone products
20 Jun 2007 Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
20 Jun 2007 ConjuChem Biotechnologies Reports PC-DAC(TM):Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
19 Jun 2007 Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
19 Jun 2007 Presentation of In Vivo HDL Kinetic Data at the European Atherosclerosis Society 76th Congress Demonstrates Activation of Reverse Cholesterol Transport by Pre-Beta HDL in Selectively Delipidated

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top